Glebe et al., 2003 - Google Patents
Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virusGlebe et al., 2003
View PDF- Document ID
- 6765151130813435446
- Author
- Glebe D
- Aliakbari M
- Krass P
- Knoop E
- Valerius K
- Gerlich W
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
The susceptibility of the tree shrew Tupaia belangeri to human hepatitis B virus (HBV) has been demonstrated both in vivo and in vitro. In this study, we show that purified HBV infects primary T. belangeri hepatocyte cultures in a very specific manner, as detected by HBV …
- 241000700721 Hepatitis B virus 0 title abstract description 150
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
- C12N2730/00011—Reverse Transcribing DNA Viruses
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
- C12N2730/00011—Reverse Transcribing DNA Viruses
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
- C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
- C12N2770/24011—Flaviviridae
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Glebe et al. | Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus | |
| Gerlich | Medical virology of hepatitis B: how it began and where we are now | |
| Hong et al. | Characterization of hepatitis B precore/core-related antigens | |
| Wu et al. | Hepatitis B virus infection: Defective surface antigen expression and pathogenesis | |
| Patient et al. | Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking | |
| OU | Molecular biology of hepatitis B virus e antigen | |
| Chouteau et al. | A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus | |
| Ito et al. | Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site | |
| Freitas et al. | Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles | |
| Köck et al. | Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus | |
| Gerlich | Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives | |
| Schulze et al. | Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction | |
| Barrera et al. | Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition | |
| Glebe et al. | The molecular virology of hepatitis B virus | |
| Chai et al. | Properties of subviral particles of hepatitis B virus | |
| Ni et al. | The pre-s2 domain of the hepatitis B virus is dispensable for infectivity but serves a spacer function for L-protein-connected virus assembly | |
| Blum | Hepatitis B virus: significance of naturally occurring mutants | |
| Sureau et al. | Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens | |
| Yuan et al. | Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen | |
| Raney et al. | The biology of hepatitis B virus | |
| Watashi et al. | Hepatitis B virus and hepatitis D virus entry, species specificity, and tissue tropism | |
| Le Pogam et al. | Influence of a putative intermolecular interaction between core and the pre-S1 domain of the large envelope protein on hepatitis B virus secretion | |
| Pumpens et al. | Molecular epidemiology and immunology of hepatitis B virus infection–an update | |
| Yuan et al. | Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation | |
| Ning et al. | Nucleolar localization of human hepatitis B virus capsid protein |